The federal Food and Drug Administration has approved a new, scalpel-free treatment for tremor in patients with medication-resistant Parkinson's disease.
The procedure, called focused ultrasound, allows doctors to perform brain surgery without cutting into the skull. It was shown safe and effective for reducing medication-resistant Parkinson's tremor in clinical trials led by neurosurgeon Jeff Elias, MD, of the University of Virginia School of Medicine.
"We are very excited about this approval," Elias said. "Now, patients with Parkinson's disease will have more options if their symptoms become refractory to medication."
UVA previously led the clinical research that paved the way for FDA approval of the technology for treating essential tremor, a common movement disorder affecting millions of Americans.
Parkinson's disease drug disrupts the gut microbiome by inducing iron deficiency